CEO of Kips Bay Medical (KIPS) Announcs Disappointment With FDA Following Clinical Study of eSVS MESH
Go back to CEO of Kips Bay Medical (KIPS) Announcs Disappointment With FDA Following Clinical Study of eSVS MESH| KIPS BAY MEDICAL (NASDAQ: KIPS) | Delayed: 0.27 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.27 | 52 Week High | $0.30 | |||
| Open | $0.20 | 52 Week Low | $0.01 | |||
| Day High | $0.27 | P/E | N/A | |||
| Day Low | $0.27 | EPS | $-0.26 | |||
| Volume | 6,329 | |||||
